Jane Aldrich, Ph.D., joined the College of Pharmacy at the University of Florida as a professor of medicinal chemistry in 2015. She came to the University of Florida from the University of Kansas, where she had been a professor since 2001. She received her Ph.D. from the University of Michigan and completed an NIH postdoctoral fellowship at the University of Minnesota.
The focus of research in her laboratory is the design and synthesis of peptides and peptidomimetic analogs. This research involves examining structure-activity relationships, primarily of opioid peptides, and exploring synthetic methodologies to prepare novel peptide and peptidomimetic analogs. Her research has expanded to also include studies related to drug development, examining the metabolic stability of peptides, their ability to cross biological barriers, and their pharmacokinetic and pharmacological properties in animal models. Current projects focus on novel peptide analogs as potential treatments for drug abuse, pain and cancer.
Dr. Aldrich is currently a Councilor for the Medicinal Chemistry Division (2014-2019) of the American Chemical Society and was previously Chair of the division (2000). She also is on the editorial board of the Journal of Medicinal Chemistry (2016-2018) and is chair the NIH Drug Discovery for the Nervous System study section (2017-2019). In addition, she has served as President of the American Peptide Society (2005-2007) and Co-Chair of the Gordon Research Conference on the Chemistry and Biology of Peptides (2004).